Skip to main content
Jens Hillengass, MD, Hematology, Buffalo, NY

JensHillengassMDPhD

Hematology Buffalo, NY

Hematologic Oncology

Physician

Dr. Hillengass is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hillengass' full profile

Already have an account?

  • Office

    Elm and Carlton Streets
    Buffalo, NY 14263
    Phone+1 716-845-2300
    Fax+1 716-845-2293

Summary

  • Dr. Jens Hillengass is a hematologist in Buffalo, NY and is affiliated with Roswell Park Comprehensive Cancer Center. He received his medical degree from University of Heidelberg Faculty of Medicine and has been in practice 15 years. He specializes in hematologic oncology and is experienced in multiple myeloma, amyloidosis, stem cell transplantation, hematologic oncology and hematologic malignancies.

Education & Training

  • University of Heidelberg Faculty of Medicine
    University of Heidelberg Faculty of MedicineClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2025

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Bortezomib-Based Induction and Maintenance Overcomes the Negative Prognostic Impact of Renal Impairment and del17p in Transplant-Eligible Myeloma Patients: Long Term R...
    Jens Hillengass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Cytogenetic Abnormalities in Monoclonal Gammopathy of Undetermined Significance 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows
    Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team ShowsDecember 8th, 2024
  • Harpoon Therapeutics : ASH2022 Interim Clinical
    Harpoon Therapeutics : ASH2022 Interim ClinicalDecember 12th, 2022
  • Roswell Park Sequencing Study Unlocks Mystery of Multiple Myeloma
    Roswell Park Sequencing Study Unlocks Mystery of Multiple MyelomaFebruary 14th, 2022
  • Join now to see all

Committees

  • Vice-Chair for Imaging, Myeloma Committee, Alliance for Clinical Trials 2022 - Present
  • Co-Chair for Imaging and Bone Disease, International Myeloma Working Group 2020 - Present
  • Member Amyloidosis, Multiple Myeloma, Waldenström Macroglobulinemia, NCCN 2018 - Present

Other Languages

  • German